PT  - JOURNAL ARTICLE
AU  - Campbell-Yeo, Marsha
AU  - Dol, Justine
AU  - Richardson, Brianna
AU  - McCulloch, Holly
AU  - Hundert, Amos
AU  - Foye, Sarah
AU  - Dorling, Jon
AU  - Afifi, Jehier
AU  - Bishop, Tanya
AU  - Earle, Rebecca
AU  - Rose, Annette Elliott
AU  - Inglis, Darlene
AU  - Kim, Theresa
AU  - Leighton, Carye
AU  - Loring, Sally
AU  - MacRae, Gail
AU  - Melanson, Andrea
AU  - Simpson, David C
AU  - Smit, Michael
AU  - Whitehead, Leah
TI  - Development of clinical virtual care pathways to engage and support families requiring neonatal intensive care in response to the COVID-19 pandemic (COVES Study)
AID  - 10.1101/2021.03.29.21254567
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.03.29.21254567
4099  - http://medrxiv.org/content/early/2021/03/31/2021.03.29.21254567.short
4100  - http://medrxiv.org/content/early/2021/03/31/2021.03.29.21254567.full
AB  - Background In response to the COVID-19 pandemic, family presence restrictions in neonatal intensive care units (NICU) were enacted to limit disease transmission and protect infants, families, and healthcare providers. The effects of pandemic parental restrictions on providing optimal family integrated neonatal care is unknown.Aim To ensure optimal neonatal care using virtual care pathways to engage and support families in response to parental presence restrictions imposed during the COVID-19 pandemic. The research had two objectives: (1) conduct a needs assessment with families and healthcare providers (HCPs) of infants in the NICU to understand the impact of COVID-19 restrictions; and (2) develop virtual clinical care pathways to meet identified needs.Methods This study used focus groups and individual semi-structured interviews with families and HCPs for the needs assessment and identification of barriers and facilitators, and co-design for the development of the clinical virtual care pathways. For objective 1, content analysis was conducted by two independent reviewers to categorize findings and identify important barriers and facilitators of family-integrated care. For objective 2, an agile, co-design process utilizing expert consensus of a large interdisciplinary team was used to develop the care pathways.Results A total of 23 participants were included in the needs assessment (objective 1): 12 families and 11 HCPs. Themes identified were: (1) the need to maintain and build relationships and support systems; (2) challenges in accessing education and resources to integrate families in care; and (3) lack of standardized, accessible messaging related to COVID-19. For objective 2, we used the themes identified in the needs assessment to co-design three clinical virtual care pathways: (1) building and maintaining relationships between family and healthcare providers; (2) awareness of resources; and (3) standardized COVID-19 messaging.Conclusion Families reported that restrictive parental presence policies affected their mental health, well-being and social support. Families and HCPs reported the restrictions impacted delivery of family integrated care, education, transition to home, and standardized messaging. Clinical care virtual pathways were designed to meet these needs to ensure more equitable family centred care.Competing Interest StatementThe authors have declared no competing interest.Funding StatementFunding for this project was from the Nova Scotia COVID-19 Health Research Coalition through the IWK Foundation.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical approval was received through IWK Health prior to recruitment (REB #1025748).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data that support the findings of this study are available from the corresponding author, [MCY], upon reasonable request.